The introduction of nicotinamide to be a nicotine substitution in e-cigarette and smokeless solutions signifies a substantial regulatory obstacle to the FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to act as a sedative at substantial dosages6. The claims made by Nicotine River, ECBlend, and various sellers that t